Genetic variation in complement factor I (CFI) leading to reduced FI levels or impaired FI function has been associated with diseases such as age-related macular degeneration (AMD) and atypical hemolytic uremic syndrome (aHUS) (2, 3). Here, CFI is linked to age-related macular degeneration.